SCHEMBL7848012

SCHEMBL7848012

Cc1cc(C(=O)CBr)cc(C)c1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
HPGD P15428 1/20 0.50
PTPN1 P18031 2/20 0.47
GSK3B P49841 1/20 0.47
GLRA1 P23415 1/20 0.47
MRGPRX4 Q96LA9 1/20 0.46
THRA P10827 1/20 0.46
THRB P10828 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAOB P27338 2/20 0.44
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
FFAR4 Q5NUL3 1/20 0.44
EGFR P00533 1/20 0.44
TAOK1 Q7L7X3 1/20 0.43
TAOK3 Q9H2K8 1/20 0.43
NR4A2 P43354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6811950 0.87 SMN1; SMN2 (0.57) LMNAHPGDPTPN1GLRA1MRGPRX4
SCHEMBL262646 0.84 MEN1 (0.63) LMNAHPGDPTPN1GLRA1MRGPRX4
SCHEMBL2341267 0.84 SMN1; SMN2 (0.50) LMNAHPGDPTPN1GSK3BTHRA
Hydrochloric Acid SCHEMBL16143479 0.83 MEN1 (0.61) LMNAHPGDPTPN1GLRA1MRGPRX4
SCHEMBL4784102 0.83 MAOB (0.59) LMNAHPGDPTPN1GLRA1MRGPRX4
SCHEMBL1437989 0.83 FFAR4 (0.58) HPGDMRGPRX4RXRARXRBRXRG
SCHEMBL4728149 0.83 HPGD (0.55) LMNAHPGDPTPN1GLRA1MRGPRX4
SCHEMBL348412 0.82 GLRA1 (0.68) LMNAHPGDPTPN1GLRA1MRGPRX4
SCHEMBL12694523 0.82 LMNA (0.47) LMNAHPGDPTPN1GLRA1MRGPRX4
SCHEMBL12692634 0.82 HPGD (0.47) LMNAHPGDPTPN1GLRA1MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783505-B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2001-03-07 EP disclosed
CN-1046731-C Pyrrolo [2,3-d ] pyrimidines and their use NOVARTIS AG (CH) 1999-11-24 CN disclosed
US-5869485-A Pyrrolo 2,3-d!pyrimidines and their use NOVARTIS FINANCE CORP. (US) 1999-02-09 US disclosed
CN-1164234-A Pyrrolo [2, 3-d ] pyrimidines and their use NOVARTIS AG (CH) 1997-11-05 CN disclosed
EP-0783505-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE Novartis AG (CH) 1997-07-16 EP disclosed
WO-1996010028-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 1996-04-04 WO disclosed